MedPath

Ambu® Auragain™ as a Conduit for Intubation in Paediatrics

Not Applicable
Completed
Conditions
Pediatric Endotracheal Intubation
Interventions
Device: Intubation via AMBU® AURAGAIN™
Registration Number
NCT03955094
Lead Sponsor
University of Malaya
Brief Summary

This study will be conducted as a prospective observational study

This study will be done in any of the operating theatres of University Malaya Medical Centre

This study will involve paediatric cases ( ages 3-12 years )posted for elective operations which require general anaesthesia with endotracheal intubation

Ambu Aura Gain will be used as a conduit for intubation

Detailed Description

All eligible participants will be approached and recruited Informed consent will be obtained Induction of general anesthesia will be as per usual standardized method Ambu® Auragain™ will be inserted A paediatric flexible endoscope will be used to view the glottis and railroad an endotracheal tube into the trachea Placement is confirmed and number of attempts and time required for successful intubation is recorded Ambu® Auragain™ will be removed Number of attempts and time taken for removal of Ambu® Auragain™ will be recorded Any complications will be noted and recorded

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Paediatric patients aged 3 - 12 years old
  • American Society of Anaesthesiologist (ASA) 1-2 patients
  • Patients must require standard endotracheal intubation for the procedure posted
Exclusion Criteria
  • Documented history of difficult airway in previous general anaesthesia
  • Clinical features of difficult airway on physical examination
  • Syndromic patients, facial deformities, dental deformities, patients with facial trauma
  • Patients with recent (less than 2 weeks) or ongoing upper respiratory tract infection
  • Patients with existing pulmonary diseases or any risk of bronchospasm
  • Patients with known gastric outlet obstruction, reflux disease, or any risk of aspiration
  • Any other contraindication for device placement
  • Operations requiring specialised endotracheal tubes
  • Emergency operations or unanticipated difficult airway cases
  • Refusal of parental informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AMBU® AURAGAIN™ deviceIntubation via AMBU® AURAGAIN™Assess feasibility of AMBU® AURAGAIN™ as an intubating device in paediatrics
Primary Outcome Measures
NameTimeMethod
Time taken to successful intubation via the Ambu® AuraGain™Time taken during procedure ( measured in seconds )

Successful intubation is confirmed via the equal air entry heard bilaterally on auscultation and a positive capnograph tracing

Secondary Outcome Measures
NameTimeMethod
Time taken required for removal of Ambu® AuraGain™ post intubationTime taken during procedure ( measured in seconds )

Successful removal of device is confirmed by equal air entry heard bilaterally on auscultation and a positive capnograph tracing

Trial Locations

Locations (1)

University of Malaya

🇲🇾

Kuala Lumpur, Malaysia

© Copyright 2025. All Rights Reserved by MedPath